Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes

被引：82
作者：
Harenberg, J [1 ]
机构：
[1] Univ Hosp, Dept Internal Med & Geriatr, Mannheim, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 04期
关键词：
D O I：
10.1111/j.1538-7933.2004.00647.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：547 / 550
页数：4
相关论文
共 27 条
  • [11] HARENBERG J, 1989, NOUV REV FR HEMATOL, V31, P363
  • [12] HARENBERG J, 1988, THROMB HAEMOSTASIS, V60, P377
  • [13] HARENBERG J, 1989, THROMB HAEMOSTASIS, V61, P357
  • [14] Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis
    Harenberg, J
    Stehle, G
    Blauth, M
    Huck, K
    Mall, K
    Heene, DL
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (01) : 83 - 90
  • [15] Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
    Hirsh, J
    Warkentin, TE
    Shaughnessy, SG
    Anand, SS
    Halperin, JL
    Raschke, R
    Granger, C
    Ohman, EM
    Dalen, JE
    [J]. CHEST, 2001, 119 (01) : 64S - 94S
  • [16] HOLMSTROM M, 1992, THROMB RES, V67, P49
  • [17] SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH CONTINUOUS INTRAVENOUS HEPARIN IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS
    HULL, RD
    RASKOB, GE
    PINEO, GF
    GREEN, D
    TROWBRIDGE, AA
    ELLIOTT, CG
    LERNER, RG
    HALL, J
    SPARLING, T
    BRETTELL, HR
    NORTON, J
    CARTER, CJ
    GEORGE, R
    MERLI, G
    WARD, J
    MAYO, W
    ROSENBLOOM, D
    BRANT, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (15) : 975 - 982
  • [18] Laposata M, 1998, ARCH PATHOL LAB MED, V122, P799
  • [19] LEVINE MN, 1989, THROMB HAEMOSTASIS, V62, P940
  • [20] LINDMARKER P, 1994, THROMB HAEMOSTASIS, V72, P186
123